Early Detection Leaders

About - Company Bios

Board of Directors:

Dr. Michael. A. Huchital, Ph.D., Chairman and Chief Medical Officer Dyne Immune Institute for Translational Medicine and Research has developed over 100 Immunoassays for the quantitation of therapeutic drugs in serum and urine and quantitation and detection of infectious diseases, bio-toxins, agricultural contaminants, and industrial wastes. Prevnar vaccine, used for the prevention of Pneumococcal Pneumonia, is one of the most successful vaccines of the 20th and 21st centuries. Dr. Huchital played a pivotal role in its development. Dr. Huchital developed innovative physicochemical-immunoassay analytical techniques for the determination of the chemical integrity of Prevnar. These analytical techniques are now the standard methods for evaluation of all new vaccine cocktails.

Dr. Hutchital is an expert in the following fields: Physical biochemistry regarding circular dichroism, optical rotator dispersion, POLARIMETRY, and NMR. Additionally, Dr. Hutchital is an expert in liquid chromatography, bacterial membrane transport kinetics; he is also an accomplished synthetic bioorganic chemist and microbiologist.

Mr. Paul L McGehee is President & CEO, Dyne Immune Institute for Translational Medicine and Research. Mr. McGehee was founder President & CEO of Allete Pharmaceuticals. Allete has unique antimicrobial medical food technology that eradicates bacteria associated with nosocomial infections. Mr. McGehee is currently collaborating with Trina Artificial Pancreas System" ('APS') for treatment of diabetes and its major co-morbidities of neuropathy, nephropathy, retinopathy, decubitus ulcers, and hypertension. APS is uniquely potent in addressing diabetes and its many major co-morbidities, and likely constitutes one of the more significant medical technology breakthroughs of the 21st Century. For over twenty years, Mr. McGehee has served on several boards, which promote quality of life issues around the world. In addition, Mr. McGehee is an officer at Parks Chapel AME Church.

Advisory Board of Directors:

Dr. Charles Rupprecht, VMD, MS, Ph.D. Former Chief, Rabies Section Viral and Rickettsial Zoonoses Branch, Division of Viral and Rickettsial Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention.

Dr. Charles Rupprecht obtained his veterinary degree from the University of Pennsylvania in 1985 and his Ph.D. in Biological Sciences from the University of Wisconsin. He currently serves as Chief, Rabies Section, Viral and Rickettsial Zoonoses Branch, Division of Viral and Rickettsial Diseases, National Center for Infectious Diseases at the Centers for Disease Control and Prevention in Atlanta, Georgia.

Dr. Rupprecht has also served as Director, World Health Organization Collaborating Center for Rabies Reference and Research. He has won numerous federal service awards, including the National Center for Infectious Diseases Public Health Protection Research Award in 2005, Honorary Diplomate of American Veterinary Epidemiology Society in 2003, the EPMS/PMRS Performance Award from 2001 through 2005, 1997, 1996, and in 1993. He serves on many Advisory Committees and has written over 200 publications.

Dr. Pooya Beigi

Pooya Beigi, MD, MSc, MPH is a Dermatologist (London, UK), Clinical Research Fellow at the University of British Columbia (Vancouver, BC, Canada) and the President/Owner of the NWM Medical Clinic (Canada). He is also the Founder/CEO of the Misdiagnosis Association and Research Institute (MARI), Mismedicine Organization and Research Institute, both in Beverley Hills, CA, USA, and Founder/CEO of Father Medical Charity (Vancouver, BC, Canada).

Dr. Beigi established "MARI" with the aim of collecting and preparing the most comprehensive databases of misdiagnosis and error in medicine cases and conducting related medical research studies in collaboration with health organizations, universities, clinics, professors, and physicians from all around the world.

Also, he founded Father Medical Charity with the goal of helping patients in need, especially those in underdeveloped countries. This charity collaborates with many physicians and nurses employed in underdeveloped countries who identify patients in need and refer them to this medical charity to receive the necessary medications or facilitate treatments for them.

He is the author of several books in the medical field, including Acrodermatitis Enteropathica; A Clinician's Guide (2015), A Clinician's Guide to Mycosis Fungoides (2016), A Clinician's Guide to Pemphigus Vulgaris (2016), A Clinician's Guide to Psoriasis (2019), and A Clinician's Guide to Alopecia Areata (2017).

Dr. Frank Arnold, Ph.D., Senior Program Manager, BARDA/ASPR/Health Human Services. Frank Arnold is a consultant in support of the Biomedical Advanced Research and Development Authority (BARDA) in the Office of the Assistant Secretary for Preparedness and Response (ASPR) within the U.S. Department of Health and Human Services (HHS). Dr. Arnold joined the Pandemic Influenza program in March of 2009, where he provides technical support and program management to the recombinant and cell culture-based vaccine programs. He also provides subject matter expertise for product development activities from laboratory experiments through transfer to final manufacturing.

Prior to joining the BARDA team, Dr. Arnold led the process development department in R&D at Sanofi Pasteur in Swiftwater, PA, for over 10 years. There he managed activities ranging from microbiology/fermentation development, downstream processing through to formulation and fill/finish for clinical trial materials. During his tenure with Sanofi, he and his team made significant contributions to the licensure of the H5N1 influenza vaccine, Fluzone ID, Fluzone HDIM, and Menactra. He also made significant contributions to vaccines currently under development, including live Dengue vaccine, various therapeutic cancer vaccines, pediatric meningitis vaccines, and pneumococcal vaccines. Prior to Sanofi, Dr. Arnold worked at Wyeth in the vaccine division (Wyeth Lederle Vaccines and Pediatrics/Lederle Praxis Biologicals) for 10 years. There he led scientific teams in various areas including, analytical development, purification development, formulation development, and manufacturing support. He made significant contributions to the licensure of Prevnar for both process and analytical technologies and also a number of pediatric combination products, including Accel-Immune, Tetramune, and Tetracel, as well as working on various novel candidates including polio, RSV, and Herpes. Dr. Arnold brings extensive expertise in vaccinology that includes both scientific and managerial disciplines for vaccine targets of viral, bacterial, and therapeutic origins.

Dr. Arnold received a BS in Chemistry from New York University and his Ph.D. in Biochemistry from New York University. He was a postdoctoral scientist at American Cyanamid Medical Research Division in Pearl River, New York.

Mr. Dan Fisher is the owner of the Kollaborative venture, founder and president of BioZone Laboratories, Inc., has extensive experience in the development and manufacturing of hundreds of products in the pharmaceutical industry. Currently, he is an officer of Nano BioMed, a collaboration for advanced nano-drug delivery technology. The company has collaborated with Einstein Medical School in New York. He has been involved with some of the most important technologies in the 20th and 21st centuries.
Mr. Wilfred McGehee's background includes President & CEO of a multi-million dollar contracting company for the federal government. The company specialized in maintenance and sanitary supply services for military bases throughout the country. Company Contracted with several military bases including Seal Beach Naval Weapons Station, Alameda Naval Air Station, Marine Logistics base Albany, GA., and South Carolina Naval base, to name a few. Coordinated and executed all services by way of government administrators and high ranking military officers. Mr. McGehee has also been a senior executive for a prominent California mortgage banking company in Northern California, with sales in excess of 2 billion dollars per year. His responsibility included building and managing the sales team to market various products ranging from A-paper to sub-prime products. He successfully expanded the operation and increased sales throughout the Northern California district. In addition, Mr. McGehee was a partner in a major California-based investment firm that purchased, rehabilitated, and sold single-family residences in Northern California primarily to first-time home buyers. Mr. McGehee has been a consultant to various non-profit groups helping to improve the housing stock in Northern California by way of various government programs where he coordinated acquisition of real estate, rehabilitation, and exit strategies by way of affordable housing programs. Mr. McGehee has an extensive background in economics, finance, investment analysis, market trends, and strategic real estate acquisition.

Dr. Jeffrey M. Becker

Dr. Jeffrey M. Becker is Chancellor's Professor and Head of the Department of Microbiology in the College of Arts and Sciences at the University of Tennessee, Knoxville. Dr.Becker received a B.A. in biology from Emory University and a Ph.D. in microbiology from The University of Cincinnati. He was trained in biophysics at the Weizmann Institute in Rehovot, Israel, as a Weizmann Fellow and a NATO/NSF Postdoctoral Fellow under Professors Ephraim Katzir and Meir Wilchek. After his postdoctoral fellowship, Dr. Becker was appointed Assistant Professor in Microbiology at the University of Tennessee, Knoxville, in 1972. Dr. Becker's major research interests are in the structure and function of peptides and their receptors, membrane transport, and medical mycology.

Dr. Becker has published over 240 peer-reviewed articles and has been awarded grants for research from many agencies, including the National Institutes of Health (NIH), the American Cancer Society, and the National Science Foundation. He was awarded a Research Career Development Award from NIH, was named a UT Chancellor's Research Scholar, received UT's Alexander Prize exemplifying the ideal teacher-scholar, and was Marshall of the University of Tennessee College of Arts & Sciences. Dr. Becker has been elected as a Fellow of the American Academy of Microbiology and the American Association for the Advancement of Science. In 2011Dr. Becker was named Chancellor's Professor, the highest lifetime honor that can be accorded to a member of the faculty of the University of Tennessee, Knoxville.

He currently holds an NIH grant in the 34th year of continuous funding. He has served on many NIH study sections, currently serving on the Drug Discovery and Mechanisms of Antimicrobial Resistance panel, on the editorial board of Antimicrobial Agents and Chemotherapy, and as Associate Editor of the journal Microbiology. Dr. Becker has served as a consultant to the pharmaceutical companies Eli Lilly, Merck, Smith-Kline Beckman, Magainin Sciences, and Elytra.

Dr. Becker was one of the four founders of a new biotechnology company located in Cambridge, Massachusetts, whose goal was to find and develop new drugs for infectious diseases. That company, Mycopharmaceuticals, Inc., merged subsequently with Millenium Pharmaceuticals, Inc.

The research carried out in Dr. Becker's laboratory involves the molecular biology of membrane transport, the structure and function of peptide pheromones/hormones and their receptors, and the discovery of fungal virulence factors. Dr. Becker has trained over thirty doctoral students who have taken postdoctoral fellowships at institutions, including U. California-Berkeley, Columbia University, Johns Hopkins, Case Western, Vanderbilt, Harvard, and CalTech. His former students now hold faculty or staff positions at St. Michael's College, U. Alabama, National Cancer Institute, FDA, New Mexico State, Nebraska Wesleyan, Centers for Disease Control, Brown U., Clark Atlanta U., Rhodes College, U. North Dakota, Purdue, and Case Western.

Dr. Nan-Loh Yang Ph.D

Chair, Polymer Division, Ph.D. Program in Chemistry, Graduate Center, CUNY and Professor City University of New York, Graduate School and College of Staten Island.

His laboratory has a track record of providing undergraduates with an environment conducive to the development of their scientific interest, combining independent work with the support of postdoctoral fellows and doctoral students. Two areas are open to beginning students: organic nanostructures and inorganic-organic nanomagnet hybrids.

The organic nanostructures area includes unimolecular micelles and multiblock copolymers with well-defined macromolecular architectures. In this project, students learn to conduct ionic and "living-free radical" copolymerizations for the preparation of nanosystems with well-controlled dimensions as well as targeted topology.

The inorganic-organic nanomagnet hybrids area involves studies of magnetic nanoparticles (5 to 20 nm) coated with organic monolayers. Paramagnetic and superparamagnetic properties are examined using state-of-the-art instrumentation, including Fourier–transform electron spin resonance spectroscopy.

Dr. Bob Arnot, MD

Dr. Arnot serves CHIEF EDUCATOR AND WELLNESS OFFICER of LTS Nutraceuticals, Inc. Dr. Arnot served as Chief Medical Educator of Connectyx Technologies Holdings Group, Inc. Dr. Arnot is the official livethesource chief educator and wellness officer. Dr. Arnot served as Chief Knowledge Officer of Connectyx Technologies Holdings Group, Inc. since 2009. Dr. Arnot is a renowned medical doctor, an award-winning television correspondent, and an international humanitarian. ... His stellar broadcast career has included stints as the chief medical correspondent for NBC News, chief foreign correspondent and special foreign correspondent for MSNBC.

Dr. Arnot is a physician and international humanitarian figure with extensive experience in healthcare and news media. He is one of the most recognized figures in medical journalism. His broadcast career has included: Foreign correspondent and chief medical correspondent for NBC News (including Dateline, The Today Show, and the NBC Nightly News), chief foreign correspondent, and special foreign correspondent for MSNBC News. He was a health correspondent for CBS News (including CBS Evening News, CBS This Morning and CBS Morning News), NBC, Google Health, General Mills, and WebMD. He has also been featured in national television specials on international health and humanitarian topics for Discovery Health, Discovery Military, PAX, the ABC Family Channel, BET, and FOX. He began his medical career as the founder and chief of the Lake Placid Sports Medical Center, where he not only served as administrator but also as the physician from 1977 to 1980 U.S. Ski Team and the 1980 Winter Olympic Games. He was an NBC Chief Medical Editor. Dr. Arnot is also known as Dr. Danger from his highly successful reality series, which chronicles his travels around the globe to places like South Africa, Syria, Botswana, Yemen, and Afghanistan. Dr. Arnot served as Board of Directors for the U.S. Ski Team. Dr. Arnot is also a highly successful author, having published numerous books and articles and columns on health issues ranging from sports science and physical fitness to breast cancer.

Dr. Arnot has also been involved in numerous international medical and humanitarian organizations. He was the medical director for National Emergency Services. He served as a physician providing humanitarian relief in countries including; Somalia, Sudan, Rwanda, Armenia, Congo, Sierra Leone, Kosovo, and Iraq. He founded Operation Lifeline Iraq. Dr. Arnot serves as Member of Advisory Board - Media and Business of LifeMed Media, Inc. Dr. Arnot serves as Member of Advisory Board of LTS Nutraceuticals, Inc. He served as a Member of the Advisory Board (Media) of Lifemed Media Inc. His broadcast accomplishments have earned him an Emmy Award, two Emmy nominations, the Overseas Press Club Award, the Dupont Award, and recognition from Vanity Fair for "Best Embedded Reporter," Iraq Campaign. He is the author of over 13 books on healthcare and medicine. He is an author of eight books and is the voice of the dLife daily radio broadcast, the "dLife Diabetes Minute." Dr. Arnot received a bachelor of medical science degree from Dartmouth College in 1972 and a medical degree from McGill University in Montreal in 1974.

Mr. Richard Earl Barber is a graduate of North Carolina A&T State University with a Bachelor of Science degree in Physics and graduate school at the University of Southern California with a Master of Science degree in Systems Management. He co-founded Urban Talent Development (UTD) Inc., a management Development and Business Orientation Center, with Brady Keys, Jr., former Pittsburgh Steeler. During his seven years as President, UTD trained and placed more than 1400 unemployed and underemployed persons in meaningful employment. The UTD story is a classic in manpower and management success and was cited in the Congressional Record in 1974 as one of the Nation's most effective manpower development programs. Under his dynamic, creative and inspirational leadership, New World National Bank, the only African-American owned full-service commercial bank in Pennsylvania was organized in Pittsburgh. Referred to as the "Economic Evangelist," he organized 200 churches and raised $800,000.00 to open the bank on March 17, 1975.

He served as Deputy Executive Director of the National NAACP with Dr. Benjamin Hooks in New York and as Regional Administrator of the Small Business Administration in the Carter Administration. In this position, he was responsible for small business activities in the states of Pennsylvania, Delaware, Maryland, Virginia, West Virginia, and the District of Columbia. At the state level, he served as Deputy Secretary for Procurement for the Commonwealth of Pennsylvania, and Director of Purchasing for University of Medicine & Dentistry of New Jersey (UMDNJ). Some of the numerous awards and recognitions he has received include the George Washington Freedom Medals - 1963 and 1964 for creative writing. Pittsburgh Jaycees Outstanding Young Man of Pittsburgh - 1971; A&T State University National Alumni Achievement Award for 1971; one of the Ten Outstanding Young Men of America for 1975 by the U.S. Jaycees; Man of the Year in Business by the Pittsburgh Business and Professional Women for 1975; Man of the Year by the World Wide Bible Deliverance Church for 1975. In March of 1990, he was named a Distinguished Alumnus of North Carolina A&T by the National Association for Equal Opportunity in Higher Education (NAFEO). Barber served his country as a military army officer rising to the rank of Captain.

Daniel E. Lawson, PhD

Experienced, dedicated, senior executive, with strong scientific and clinical expertise within the In Vitro Diagnostics (IVDs), Medical Devices, and Biotechnology industries. Global management experience recognized w/w in building compelling product strategies, ensuring regulatory approval, and synthesizing successful launch for optimized commercial value. Broad-based results-oriented leader with Fortune, start-up, and turnaround experience.

Specialties: Expertise and experience in assay/product development, strategic planning, risk analysis, technology transfer, quality system management, clinical trial management, product acquisition, due diligence, business development, operational budgeting, strategic alliances, innovation, communication, and teambuilding.